Skip to main content
logo
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.050
+0.040 (1.00%)
At close: Apr 6, 2026, 4:00 PM EDT
4.140
+0.090 (2.22%)
After-hours: Apr 6, 2026, 4:23 PM EDT

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
951219610712-
Market Cap Growth
-11.93%26.83%-10.31%769.77%--
Enterprise Value
48.1874.657.3974.1228.10
Last Close Price
4.055.805.737.414.74-
PE Ratio
--4.57-5.85-9.38-1.00-
PS Ratio
11.9615.2826.9417.78--
PB Ratio
1.972.822.423.00-1.46-
P/TBV Ratio
1.582.262.212.11-1.46-
P/FCF Ratio
--11.31-9.30-9.54-1.70-
P/OCF Ratio
--11.31-9.30-9.54-1.70-
EV/Sales Ratio
6.069.3916.1512.35--
EV/EBITDA Ratio
--3.31-3.33-9.41-2.87-
EV/EBIT Ratio
--3.31-3.33-9.38-2.86-
EV/FCF Ratio
--6.95-5.58-6.62-3.88-
Debt / Equity Ratio
-000-1.540
Debt / EBITDA Ratio
-----1.32-
Debt / FCF Ratio
-----1.79-
Net Debt / Equity Ratio
-1.09-1.09-0.97-0.92-0.84-1.19
Net Debt / EBITDA Ratio
2.082.082.234.14-0.720.89
Net Debt / FCF Ratio
4.364.363.732.92-0.971.07
Asset Turnover
0.170.170.080.2400
Quick Ratio
7.977.9710.027.941.553.78
Current Ratio
8.508.5011.598.151.883.99
Return on Equity (ROE)
-51.39%-51.39%-39.57%-58.64%515.59%-134.25%
Return on Assets (ROA)
-47.85%-47.85%-38.44%-35.00%-148.80%-101.63%
Return on Invested Capital (ROIC)
-3039.27%-3039.23%-436.56%-552.70%953.44%699.30%
Return on Capital Employed (ROCE)
-53.32%-53.32%-44.96%-38.76%-238.86%-133.66%
Earnings Yield
-22.34%-21.90%-17.10%-10.66%-99.83%-
FCF Yield
-11.30%-8.84%-10.75%-10.48%-58.99%-
Buyback Yield / Dilution
-9.79%-9.79%-49.93%-292.40%-0.01%-
Total Shareholder Return
-9.79%-9.79%-49.93%-292.40%-0.01%-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q